We are live on
!
Find out more
Sanders Capital Portfolio holdings
AUM
$83.9B
1-Year Est. Return
37.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.72%
1 Year Est. Return
+37.89%
3 Year Est. Return
+120.64%
5 Year Est. Return
+154.21%
10 Year Est. Return
+678.77%
AUM
$8.98B
AUM Growth
+$369M
(+4.3%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
46.75%
Holding
57
New
1
Increased
35
Reduced
8
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$165M |
| 2 |
JPMorgan Chase
JPM
|
+$77.7M |
| 3 |
Citigroup
C
|
+$75.9M |
| 4 |
D.R. Horton
DHI
|
+$23.7M |
| 5 |
AET
Aetna Inc
AET
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESV
Ensco Rowan plc
ESV
|
+$159M |
| 2 |
NE
Noble Corporation
NE
|
+$156M |
| 3 |
Elevance Health
ELV
|
+$61.5M |
| 4 |
UnitedHealth
UNH
|
+$36.6M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.91% |
| 2 | Technology | 24.2% |
| 3 | Healthcare | 16.45% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ExxonMobil
XOM
$634B
| $420K | ﹤0.01% |
4,171
| – | – |
|
52
Novartis
NVS
$297B
| $407K | ﹤0.01% |
5,022
+112
| +2% | +$8.81K |
|
53
iShares MSCI Brazil ETF
EWZ
$8.95B
| $309K | ﹤0.01% |
6,467
-7,500
| -54% | -$359K |
|
54
TotalEnergies
TTE
$190B
| $173K | ﹤0.01% |
1,520,341,845
| – | – |
|
|
SNP
55
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $111K | ﹤0.01% |
1,170
| – | – |
|
|
NE
56
DELISTED
Noble Corporation
NE
| – | – |
-5,457,997
| Closed | -$156M |
|
|
ESV
57
DELISTED
Ensco Rowan plc
ESV
| – | – |
-752,178
| Closed | -$159M |
|
Similar funds
Sanders Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Sanders Capital held 57 positions worth $8.98B, up 4.3% from $8.61B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Sanders Capital's Q2 2014 filing shows 1 new, 35 increased, 8 reduced and 2 closed positions. Its largest new stake was Fifth Third Bancorp: 211,100 shares worth $4.51M. The largest sale was Ensco Rowan plc, an estimated $159M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- Sanders Capital's largest Q2 2014 buy was Fifth Third Bancorp: 211,100 shares worth $4.51M.
- Sanders Capital added most to Apple in Q2 2014, an estimated $165M increase.
- Sanders Capital's biggest Q2 2014 reduction was Elevance Health, cutting an estimated $61.5M.
- Sanders Capital fully exited Ensco Rowan plc in Q2 2014, selling an estimated $159M.
- Sanders Capital's ten largest holdings make up 47% of its $8.98B portfolio in Q2 2014.
- Sanders Capital opened 1 new position and closed 2 in Q2 2014.
- Sanders Capital's portfolio value rose 4.3% quarter-over-quarter to $8.98B.
Based on Sanders Capital's 13F filing for Q2 2014, filed 24 Jul 2014.